Some of you probably missed the launch of Global Health Nexus Seattle in all of the excitement around the Prosperity Partnership’s Luncheon with Alan Mulally. But launched it was, and there has been a lot of activity around Global Health Nexus Seattle since then, in our efforts to ensure that our region recognized internationally as the nexus of discovery, development and delivery in global health. That global awareness is the key to achieving our twin goals of simultaneously helping our region’s economy and the world’s most vulnerable citizens.
As you probably know, Nexus is a joint effort of the Prosperity Partnership, the Washington Global Health Alliance, the Washington Biotechnology and Biomedical Association, the Gates Foundation and many others. And one of the most exciting parts of that coming together is the opportunity to tie more closely the for-profit and nonprofit aspects of our region’s life sciences community. Members of both the WBBA and the WGHA are working to improve health outcomes for patients around the world, yet we have allowed tax status and organizational structure to serve as a barrier for collaboration.
And it doesn’t have to be all philanthropically focused, either. For a biotech company, the fastest emerging markets are the developing nations, and it is the global health organizations that already understand these markets. In fact, we know that the initiatives of just nine global health organizations here in Washington involve nearly 500 programs in 92 countries. Not to mention that technologies in development for global health have potential applications for the domestic population here as well. Last, but certainly not least, government and philanthropic dollars that support global health can actually fill important capital needs for life sciences companies.
BTW, I love this quote from the above-linked article:
From new vaccines for neglected diseases to small diagnostic “lab on a chip” technologies, a wide array of products are being invented in the region that have applications in health care, agriculture and biofuels. At the same time, different fields are converging — biotechnology, medicine, engineering, computing and telecommunications — to produce interesting hybrids.
My point, exactly. Which is one of the reasons that the next Prosperity Partnership Industry Cluster Tour – taking place this Friday, March 26 – is focused on biomedical devices. It’s not too late to register!